Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Synthetic RNA
100%
Truncated Forms
100%
Bifunctional
100%
NCI-H460 Cells
100%
RNA Aptamer
100%
Cell Growth
25%
Aptamer
25%
Dose Effect
12%
Quantitative PCR
12%
Diagnostic Approach
12%
Tumor Tissue
12%
Treatment Strategy
12%
Drug Development
12%
Binding Affinity
12%
Clinical Setting
12%
Cell Viability
12%
Antitumor Effect
12%
IC50 Value
12%
Novel Diagnostics
12%
Novel Treatments
12%
In Vivo Imaging
12%
Biotin
12%
Tumor Site
12%
Chemically Synthesized
12%
Xenograft Tumor
12%
By Design
12%
RNA Modification
12%
High Retention
12%
SELEX
12%
Transcribed RNA
12%
Immunology and Microbiology
Cell Growth
100%
Binding Affinity
50%
Quantitative Reverse Transcription Polymerase Chain Reaction
50%
Cell Viability
50%
Xenograft
50%
IC50
50%
Internalization
50%
Biochemistry, Genetics and Molecular Biology
RNA
100%
Aptamer
100%
Cell Growth
40%
Binding Affinity
20%
Cell Viability
20%
Quantitative Reverse Transcription Polymerase Chain Reaction
20%
Biotin
20%
IC50
20%
Internalization
20%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Aptamer
100%
Neoplasm
80%
Cell Viability
20%
IC50
20%
Drug Development
20%
Biotin
20%
Material Science
Tumor
100%
Cell Growth
50%